ArticleAdvances in radiation oncology

A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses.

Joseph Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.